Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

7.1%

1 terminated/withdrawn out of 14 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A

5(83.3%)

Phase 4

1(16.7%)

6Total

N/A(5)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (14)

Showing 14 of 14 trials

NCT07365124Not Yet Recruiting

MRinRT: Swansea University and SWWCC Collaboration Study.

Role: lead

NCT07498868Not Yet Recruiting

Detecting the Undetected: Heart Failure Screening at the Lymphoedema Point of Care

Role: lead

NCT05727020Recruiting

Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma

Role: collaborator

NCT07393932Not Yet Recruiting

MND Together: Phase 1

Role: collaborator

NCT07365072Not ApplicableRecruiting

The PRIMROSE Trial

Role: lead

NCT05219058Recruiting

Reconstruction in Extended MArgin Cancer Surgery

Role: collaborator

NCT06142071Active Not Recruiting

Mixed Methods Study to Assess Family Members Unmet Needs in an Oncology Setting

Role: lead

NCT05163873Not ApplicableCompleted

ExPECT: Extraperitoneal End Colostomy Trial

Role: lead

NCT05456568Not ApplicableCompleted

LymphAssistTM at Home (LAAH)

Role: lead

NCT05381285Unknown

Survival Model for Preterm Infants

Role: collaborator

NCT04836624Not ApplicableCompleted

Co-designing Personalised Assistive Technology

Role: collaborator

NCT05322200Phase 4Unknown

The POST-ACS Study

Role: lead

NCT04995705Not ApplicableTerminated

Evaluation of an Adapted ACT Group for Stroke & Brain Injury Survivors

Role: collaborator

NCT04382508Unknown

Coronavirus Infection in Primary or Secondary Immunosuppressed Children and Adults.

Role: collaborator

All 14 trials loaded